These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 35232622)

  • 1. APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.
    Parhizkar S; Holtzman DM
    Semin Immunol; 2022 Jan; 59():101594. PubMed ID: 35232622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
    Fernández-Calle R; Konings SC; Frontiñán-Rubio J; García-Revilla J; Camprubí-Ferrer L; Svensson M; Martinson I; Boza-Serrano A; Venero JL; Nielsen HM; Gouras GK; Deierborg T
    Mol Neurodegener; 2022 Sep; 17(1):62. PubMed ID: 36153580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.
    Chernyaeva L; Ratti G; Teirilä L; Fudo S; Rankka U; Pelkonen A; Korhonen P; Leskinen K; Keskitalo S; Salokas K; Gkolfinopoulou C; Crompton KE; Javanainen M; Happonen L; Varjosalo M; Malm T; Leinonen V; Chroni A; Saavalainen P; Meri S; Kajander T; Wollman AJ; Nissilä E; Haapasalo K
    EMBO Rep; 2023 Jul; 24(7):e56467. PubMed ID: 37155564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease.
    Ayyubova G
    CNS Neurol Disord Drug Targets; 2024; 23(3):342-352. PubMed ID: 36872358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease.
    Tzioras M; Davies C; Newman A; Jackson R; Spires-Jones T
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):327-346. PubMed ID: 30394574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the prevention and treatment of Alzheimer's disease: Control the promoters and look beyond the brain.
    Goldstein MR; Cheslock M
    Med Hypotheses; 2021 Sep; 154():110645. PubMed ID: 34315048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Insight into the Therapeutic Promise of Targeting
    Mamun AA; Uddin MS; Bin Bashar MF; Zaman S; Begum Y; Bulbul IJ; Islam MS; Sarwar MS; Mathew B; Amran MS; Md Ashraf G; Bin-Jumah MN; Mousa SA; Abdel-Daim MM
    Oxid Med Cell Longev; 2020; 2020():5086250. PubMed ID: 32509144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer's Disease.
    Kloske CM; Wilcock DM
    Front Immunol; 2020; 11():754. PubMed ID: 32425941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.
    Nelson MR; Liu P; Agrawal A; Yip O; Blumenfeld J; Traglia M; Kim MJ; Koutsodendris N; Rao A; Grone B; Hao Y; Yoon SY; Xu Q; De Leon S; Choenyi T; Thomas R; Lopera F; Quiroz YT; Arboleda-Velasquez JF; Reiman EM; Mahley RW; Huang Y
    Nat Neurosci; 2023 Dec; 26(12):2104-2121. PubMed ID: 37957317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia.
    Wang C; Xiong M; Gratuze M; Bao X; Shi Y; Andhey PS; Manis M; Schroeder C; Yin Z; Madore C; Butovsky O; Artyomov M; Ulrich JD; Holtzman DM
    Neuron; 2021 May; 109(10):1657-1674.e7. PubMed ID: 33831349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.
    Williams T; Borchelt DR; Chakrabarty P
    Mol Neurodegener; 2020 Jan; 15(1):8. PubMed ID: 32005122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits.
    Koutsodendris N; Blumenfeld J; Agrawal A; Traglia M; Grone B; Zilberter M; Yip O; Rao A; Nelson MR; Hao Y; Thomas R; Yoon SY; Arriola P; Huang Y
    Nat Aging; 2023 Mar; 3(3):275-296. PubMed ID: 37118426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Role of ApoE Fragments in Alzheimer's Disease.
    Muñoz SS; Garner B; Ooi L
    Neurochem Res; 2019 Jun; 44(6):1297-1305. PubMed ID: 30225748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and Alzheimer's Disease: Findings, Hypotheses, and Potential Mechanisms.
    Koutsodendris N; Nelson MR; Rao A; Huang Y
    Annu Rev Pathol; 2022 Jan; 17():73-99. PubMed ID: 34460318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
    Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
    Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.
    Stephen TL; Cacciottolo M; Balu D; Morgan TE; LaDu MJ; Finch CE; Pike CJ
    Acta Neuropathol Commun; 2019 May; 7(1):82. PubMed ID: 31113487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.